CLINICAL_TRIALS
trial_result
· 2018-06-12
Clinical Trial Update: Study of Nivolumab in Subjects With Relapsed or Refractory Follicular Lymphoma (FL) (CheckMate 140) [Phase 2]
Summary
Phase 2 trial update for nivolumab in relapsed or refractory follicular lymphoma completed with results posted in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bristol-Myers Squibb | Conditions: Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2018-06-12